.png){kind=logo}
Last week, I had the pleasure of meeting Mabyn and her family (pic below). Mabyn is a joyful, energetic 10-year-old who loves playing basketball, spending time outside, and hanging out with her little sister. But behind her contagious smile is a daily battle with cystic fibrosis (CF) — a genetic disease that affects the lungs and digestive system, making it hard to breathe and absorb nutrients. Every day, Mabyn takes enzymes with every meal to help her body digest food. She uses a special “shaker vest” once a day to loosen the thick mucus in her lungs, making it easier for her to breathe. Life with CF can be tough, but Mabyn is tougher. When she was just six years old, Mabyn started a new medication called Trikafta — a breakthrough treatment that has changed her life. Thanks to Trikafta, her energy levels soared, her hospital visits decreased, and she is now able to live a much healthier life. This kind of progress is only possible because of people like you. Because of donations to research, life-saving drugs like Trikafta exist today — giving individuals like Mabyn a chance to thrive. But the fight isn’t over. There are still thousands of individuals living with CF who need better treatments and, one day, a cure. Donate today — for Mabyn, and for every individual still waiting to breathe a little easier.
Welcome to Rebecca Thiem's Page
Rebecca Thiem
Rebecca Thiem
I am being honored by the Cystic Fibrosis Foundation at a special event recognizing outstanding professionals in my community. In accepting this distinction, I have committed to raise money to help the Foundation realize its mission of curing cystic fibrosis (CF) and providing all people with CF the opportunity to lead long, fulfilling lives.
Please help me meet my fundraising goal by making a donation. By supporting my fundraising efforts, you have an opportunity in your lifetime to be part of ending this disease. Please consider joining us and help make medical history.
Nearly 40,000 people in the United States have cystic fibrosis: a progressive, genetic disease that affects the lungs, pancreas, and other organs. Sixty years ago, children with CF usually did not live long enough to attend elementary school. Today, because of Foundation-supported research and care, the median survival age of people with CF is over 50. Working alongside the CF community, the CF Foundation has fostered the development of more than a dozen CF treatments and helped add decades of life for people with CF. Yet, many people with CF do not benefit from existing therapies. Our vision is a cure for every person with cystic fibrosis – a life free from the burden of this disease – and we will not leave anyone behind.
To learn more about CF and the CF Foundation, visit www.cff.org. Together, we can make a difference in the lives of those with cystic fibrosis. Thank you for supporting the mission of the CF Foundation!
Please help me meet my fundraising goal by making a donation. By supporting my fundraising efforts, you have an opportunity in your lifetime to be part of ending this disease. Please consider joining us and help make medical history.
Nearly 40,000 people in the United States have cystic fibrosis: a progressive, genetic disease that affects the lungs, pancreas, and other organs. Sixty years ago, children with CF usually did not live long enough to attend elementary school. Today, because of Foundation-supported research and care, the median survival age of people with CF is over 50. Working alongside the CF community, the CF Foundation has fostered the development of more than a dozen CF treatments and helped add decades of life for people with CF. Yet, many people with CF do not benefit from existing therapies. Our vision is a cure for every person with cystic fibrosis – a life free from the burden of this disease – and we will not leave anyone behind.
To learn more about CF and the CF Foundation, visit www.cff.org. Together, we can make a difference in the lives of those with cystic fibrosis. Thank you for supporting the mission of the CF Foundation!
APR
7
7
Comments